Practice Variation in the Evaluation and Disposition of Febrile Infants ≤60 Days of Age.


Journal

The Journal of emergency medicine
ISSN: 0736-4679
Titre abrégé: J Emerg Med
Pays: United States
ID NLM: 8412174

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 29 11 2018
revised: 08 02 2019
accepted: 04 03 2019
pubmed: 25 4 2019
medline: 31 3 2020
entrez: 25 4 2019
Statut: ppublish

Résumé

Febrile infants commonly present to emergency departments for evaluation. We describe the variation in diagnostic testing and hospitalization of febrile infants ≤60 days of age presenting to the emergency departments in the Pediatric Emergency Care Applied Research Network. We enrolled a convenience sample of non-critically ill-appearing febrile infants (temperatures ≥38.0°C/100.4°F) ≤60 days of age who were being evaluated with blood cultures in 26 Pediatric Emergency Care Applied Research Network emergency departments between 2008 and 2013. Patients were divided into younger (0-28 days of age) and older (29-60 days of age) cohorts for analysis. We evaluated diagnostic testing and hospitalization rates by infant age group using chi-square tests and by site using analysis of variance. Four thousand seven hundred seventy-eight patients were eligible for analysis, of whom 1517 (32%) were 0-28 days of age. Rates of lumbar puncture and hospitalization were high (>90%) among infants ≤28 days of age, with chest radiography (35.5%) and viral testing (66.2%) less commonly obtained. Among infants 29-60 days of age, lumbar puncture (69.5%) and hospitalization (64.4%) rates were lower and declined with increasing age, with chest radiography (36.5%) use unchanged and viral testing (52.7%) slightly decreased. There was substantial variation between sites in the older cohort of infants, with lumbar puncture and hospitalization rates ranging from 40% to 90%. The evaluation and disposition of febrile infants ≤60 days of age is highly variable, particularly among infants who are 29-60 days of age. This variation demonstrates an opportunity to modify diagnostic and management strategies based on current epidemiology to safely decrease invasive testing and hospitalization.

Sections du résumé

BACKGROUND BACKGROUND
Febrile infants commonly present to emergency departments for evaluation.
OBJECTIVE OBJECTIVE
We describe the variation in diagnostic testing and hospitalization of febrile infants ≤60 days of age presenting to the emergency departments in the Pediatric Emergency Care Applied Research Network.
METHODS METHODS
We enrolled a convenience sample of non-critically ill-appearing febrile infants (temperatures ≥38.0°C/100.4°F) ≤60 days of age who were being evaluated with blood cultures in 26 Pediatric Emergency Care Applied Research Network emergency departments between 2008 and 2013. Patients were divided into younger (0-28 days of age) and older (29-60 days of age) cohorts for analysis. We evaluated diagnostic testing and hospitalization rates by infant age group using chi-square tests and by site using analysis of variance.
RESULTS RESULTS
Four thousand seven hundred seventy-eight patients were eligible for analysis, of whom 1517 (32%) were 0-28 days of age. Rates of lumbar puncture and hospitalization were high (>90%) among infants ≤28 days of age, with chest radiography (35.5%) and viral testing (66.2%) less commonly obtained. Among infants 29-60 days of age, lumbar puncture (69.5%) and hospitalization (64.4%) rates were lower and declined with increasing age, with chest radiography (36.5%) use unchanged and viral testing (52.7%) slightly decreased. There was substantial variation between sites in the older cohort of infants, with lumbar puncture and hospitalization rates ranging from 40% to 90%.
CONCLUSIONS CONCLUSIONS
The evaluation and disposition of febrile infants ≤60 days of age is highly variable, particularly among infants who are 29-60 days of age. This variation demonstrates an opportunity to modify diagnostic and management strategies based on current epidemiology to safely decrease invasive testing and hospitalization.

Identifiants

pubmed: 31014970
pii: S0736-4679(19)30129-5
doi: 10.1016/j.jemermed.2019.03.003
pmc: PMC6589384
mid: NIHMS1523766
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

583-591

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD062477
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD085233
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Références

Ann Emerg Med. 2003 Feb;41(2):206-14
pubmed: 12548270
Pediatrics. 2004 Jun;113(6):1662-6
pubmed: 15173488
Pediatrics. 2004 Jun;113(6):1728-34
pubmed: 15173498
Blood. 2007 Mar 1;109(5):2066-77
pubmed: 17105821
J Pediatr. 1992 Jan;120(1):22-7
pubmed: 1731019
Pediatr Infect Dis J. 2007 Aug;26(8):672-7
pubmed: 17848876
Pediatrics. 1991 Oct;88(4):821-4
pubmed: 1896292
Pediatrics. 2009 Jul;124(1):30-9
pubmed: 19564280
Pediatrics. 2009 Aug;124(2):439-45
pubmed: 19620201
PLoS One. 2010 Aug 27;5(8):e12448
pubmed: 20805983
Pediatrics. 2011 Dec;128(6):e1368-75
pubmed: 22106081
Pediatrics. 2012 Mar;129(3):e590-6
pubmed: 22371459
Pediatrics. 2012 Jul;130(1):e16-24
pubmed: 22732178
Pediatrics. 1990 Jun;85(6):1040-3
pubmed: 2339027
Pediatrics. 2013 Dec;132(6):990-6
pubmed: 24218461
Health Aff (Millwood). 2013 Dec;32(12):2109-15
pubmed: 24301393
Pediatrics. 2014 Feb;133(2):187-95
pubmed: 24470644
Acad Emerg Med. 2014 Feb;21(2):171-9
pubmed: 24673673
Pediatrics. 2014 Oct;134(4):667-77
pubmed: 25266437
Pediatr Emerg Care. 2015 Jan;31(1):1-5
pubmed: 25526020
Pediatrics. 2016 Aug;138(2):
pubmed: 27382134
JAMA. 2016 Aug 23-30;316(8):846-57
pubmed: 27552618
Pediatrics. 2016 Dec;138(6):
pubmed: 27940667
Pediatr Infect Dis J. 2017 Sep;36(9):908-910
pubmed: 28472006
Pediatrics. 2017 Jul;140(1):
pubmed: 28759413
Ann Emerg Med. 2018 Feb;71(2):211-216
pubmed: 28988964
Pediatrics. 2018 Feb;141(2):
pubmed: 29339564
J Pediatr. 2018 Dec;203:86-91.e2
pubmed: 30195552
Pediatr Infect Dis J. 2019 Apr;38(4):355-361
pubmed: 30882724
J Pediatr. 1988 Mar;112(3):355-60
pubmed: 3346773
Radiology. 1988 Apr;167(1):135-7
pubmed: 3347713
J Pediatr. 1985 Dec;107(6):855-60
pubmed: 4067741
Pediatrics. 1982 Nov;70(5):802-9
pubmed: 7133831
Pediatrics. 1994 Feb;93(2):346-7; author reply 349-51
pubmed: 8121758
Pediatr Ann. 1993 Aug;22(8):462-6
pubmed: 8414701
Pediatrics. 1993 Oct;92(4):524-6
pubmed: 8414821

Auteurs

Alexander J Rogers (AJ)

Departments of Emergency Medicine and Pediatrics, University of Michigan, Ann Arbor, MI.

Nathan Kuppermann (N)

Department of Emergency Medicine, University of California, Davis School of Medicine, Sacramento, CA.

Jennifer Anders (J)

Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, MD.

Genie Roosevelt (G)

Department of Emergency Medicine, Children's Hospital Colorado, Aurora, CO.

John D Hoyle (JD)

Department of Emergency Medicine, Western Michigan University, Kalamazoo, MI.

Richard M Ruddy (RM)

Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH.

Jonathon E Bennett (JE)

Department of Pediatrics, Nemours/AI Dupont Hospital for Children, Wilmington, DE.

Dominic A Borgialli (DA)

Department of Emergency Medicine, University of Michigan, Flint, MI.

Peter S Dayan (PS)

Department of Pediatrics, New York Presbyterian-Morgan Stanley Children's Hospital, New York, NY.

Elizabeth C Powell (EC)

Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital, Chicago, IL.

T Charles Casper (TC)

Department of Pediatrics, University of Utah; Salt Lake City, UT.

Octavio Ramilo (O)

Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH.

Prashant Mahajan (P)

Departments of Emergency Medicine and Pediatrics, University of Michigan, Ann Arbor, MI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH